A STAT investigation reveals the untold story of how the company has gobbled up multiple pieces of the health care industry and exploited its growing power to milk the system for profit.
that’s kind of counter-intuitive. by over-diagnosing patients, depending on the condition, the health plan is left to foot the bill of medication over $2000 in 2025 due to the Inflation Reduction Act. They’ve really been struggling with expensive specialty drugs because of medicare and medicaid laws that pass the cost over a certain amount to the health plan. Of course they could push diagnoses that don’t require expensive medication.
that’s kind of counter-intuitive. by over-diagnosing patients, depending on the condition, the health plan is left to foot the bill of medication over $2000 in 2025 due to the Inflation Reduction Act. They’ve really been struggling with expensive specialty drugs because of medicare and medicaid laws that pass the cost over a certain amount to the health plan. Of course they could push diagnoses that don’t require expensive medication.